Noninvasive Computed Tomography-Based Quantification of Tumor Fibrosis Predicts Pancreatic Cancer Response to Gemcitabine/Nab-Paclitaxel.

Research (Wash D C) · 2025 · PMC12491862 · PMID 41049608

Europe PMC DOI

hedged sentence

0.0560

closest p · 1.1× alpha

0.0560

boldest claim

The sentences

did not reach statistical significanceP = 0.056so close (0.05 < p ≤ 0.1)

In SYSUCC, high-fibrosis patients ( n = 80) showed a longer median OS of 29.77 months compared to 22.27 months in the low-fibrosis group ( n = 57), although the difference did not reach statistical significance ( P = 0.056).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.